Toma 1 medida (15 ml) diluida en agua 15 min antes de entrenar
Se inicia con 0,25 mg semanal durante un mes
Review the option that best matches what you are looking for or currently using
Here are some of its competitors that are already FDA approved for weight management: Liraglutide (Saxenda) : This injectable medication is a once-daily GLP-1 receptor agonist approved for chronic weight management in adults with a body mass index (BMI) of 30 or greater (obesity) or 27 or greater (overweight) with at least one weight-related health condition, such as type 2 diabetes, high blood pressure, or high cholesterol
Patients with existing gastrointestinal disorders such as gastroparesis, inflammatory bowel disease, or severe reflux, those on higher semaglutide doses, and those with chronic opioid dependency
Mechanistically, GLP1RAs have a beneficial effect on different stroke risk factors, support microvascular function, and reduce inflammation and oxidative stress